Latest news with #non-COVID-19
Los Angeles Times
04-04-2025
- Sport
- Los Angeles Times
Freddie Freeman to miss at least a week after being placed on injured list
Freddie Freeman's latest ankle issue will keep him out longer than initially expected. During the Dodgers' travel day to Philadelphia on Thursday, the team announced Freeman had been placed on the 10-day injured list, retroactive to March 31. The moves means that Freeman won't be eligible to return to action until next weekend, when the club returns home for a three-game series against the Chicago Cubs April 11-13. Freeman has been out since he slipped in the shower at his home Sunday and fell, aggravating the right ankle he had surgically repaired this offseason in the process. Freeman experienced swelling in his ankle in the wake of the mishap, and required extensive sessions of treatment from the team's training staff. Despite that, he went through two days of routine pregame work this week, while missing all three games against the Atlanta Braves. And the initial expectation was that he would be available for the start of the team's Philadelphia-Washington D.C. road trip Friday. On Tuesday night, manager Dave Roberts said there was even a 50/50 shot of Freeman being back in the lineup Wednesday. Instead, Freeman will now go on the IL for the first time in his Dodgers career — and the first time for a non-COVID-19 related reason since he suffered a wrist fracture with the Braves in 2017. Even before his slip in the shower, Freeman's ankle — which he sprained in the last week of the regular season last year, and had surgically repaired after playing through the injury during the Dodgers' World Series run — was not yet back to 100%. Throughout spring training and the opening week of the season, he still required close to an hour daily pregame treatment. After playing three-straight games against the Detroit Tigers last week, he said it was 'getting a little stiff' near the end of the series. Still, Freeman said those issues were 'nothing to be ever worried about,' and was hoping the team's rare Sunday off-day would provide him further reprieve. Alas, his right foot slipped as he tried stepping into a bathtub-shower. And now, he'll have to wait at least another week before returning.
Yahoo
19-03-2025
- Health
- Yahoo
How to find out if you got your measles vaccines
Measles is spreading across the U.S. once again, with confirmed cases surpassing 300 for the first time since 2019, data from the Centers for Disease Control and Prevention shows. More: Measles is getting closer to Ohio. Here's what you can do to protect you and yours While Ohio has not yet reported any measles cases in 2025, the disease has reached neighboring states such as Kentucky, Michigan and Pennsylvania. In Kentucky, one measles case was reported in Franklin County, and health officials warned people who visited a Planet Fitness in Frankfort of possible exposure. Anyone might be wondering, when was I immunized? Am I safe? Those heading South for spring break may be particularly concerned, considering the measles outbreaks in Texas and New Mexico. Here's what you need to know. Most adults in the U.S. have been vaccinated against measles, according to the CDC, but it's important to verify. Daniel Salmon, a professor at Johns Hopkins University and expert in the epidemiology of measles outbreaks, said everyone should locate their immunization records, and parents should make sure their children got the recommended two doses of the measles vaccine. "We have a lot of susceptible kids out there," Salmon said. "Measles is really infectious." If you're not sure where to start, here's a list of people and organizations you can reach out to: Ask your parents or other caregivers if they've kept records of your immunizations from childhood. Contact your high school or college, which likely required certain immunizations, to see if they kept records that you provided them. Remember that they likely won't keep your records more than one to two years after you graduate. Check with previous employers. Your doctor or public health clinic may have vaccination records for a limited number of years. While there is no national registry for vaccine history, you can check with your state's department of health. Both Ohio and Kentucky maintain statewide immunization registries, so you can request vaccine records directly or through your doctor, who may be able to access the system. For Ohio, click here for instructions for requesting vaccine records and for Kentucky, click here. Keep in mind that in Ohio, medical providers are not required to report non-COVID-19 related immunization records to the state, so it is possible that they may not have a complete list of your vaccinations. Finally, Salmon said, "If you can't find your vaccine record, I would talk to your doctor." Depending on your medical history and the vaccination rates in the area where you live, your doctor may recommend that you get the vaccine, even if you might have been immunized as an infant. Measles is a highly contagious respiratory disease that spreads through coughing and sneezing. It can cause serious complications, such as pneumonia and encephalitis, for children under 5 years old. The two-dose measles, mumps and rubella vaccine is highly effective, reducing your chance of getting the disease by 97%, but 95% of people in a community need to be vaccinated to reach herd immunity, according to Salmon. "When you have these pockets of low vaccine coverage," Salmon said, "that's where you see outbreaks." This article originally appeared on Cincinnati Enquirer: Measles vaccine: How to figure out if you got one
Gulf Insider
21-02-2025
- Health
- Gulf Insider
500+ COVID Studies Retracted for Unreliable Data
Retractions are driven by pressure to produce studies quickly, watchdog co-founder says More than 500 studies on COVID-19 have been withdrawn due to 'bias,' 'unreliable' information, or unspecified reasons, a blog that tracks retracted documents, found. Retraction Watch co-founder Ivan Oransky told The College Fix via phone interview one reason for the high number of retractions is the academic system's incentive structure which pressures researchers to rapidly produce studies and get them peer reviewed as quickly as possible. 'Why do they feel the need to rush papers through? Well, it's because that's how they get or keep their jobs, that's how they get grants, everything is based on that,' he said. 'When you know that your whole career depends on publishing papers in particular journals, you're going to do what you have to do to publish those papers. Most of the time that means you work hard, you hire the smart grad students and postdocs,' he said. Oransky also said researchers may feel 'too desperate' or that 'incentives are so stark' that there's no 'humanly possible way' to do it. 'So you start engaging in misconduct,' he said. The articles in the list pertain to risk factors related to COVID-19 vaccines and various alternative treatments for the disease. 'It's really a range of everything from essays to big clinical trials,' he said. Oransky pointed The Fix to one of his research letters examining the differences between retractions of COVID-19 and non-COVID-19 related research papers. The results showed that papers on COVID-19 had a higher likelihood of being retracted or withdrawn within the first six months of publication and that they were more likely removed 'without detailed explanation or for non-misconduct-related concerns.' He said retracting papers is not necessarily a bad thing, as it can correct information that was potentially wrong or misleading. Ensuring clear and concise reasoning for retractions is crucial, he told The Fix . 'The problem is when papers aren't retracted. The problem is when papers sit in the literature, people know there's a problem, but everybody refuses to do anything about them,' Oransky said. Further, many people use retractions to argue the government, drug companies, and others are untrustworthy. Generally, those people either 'have an axe to grind' or are 'just trying to sell the public something,' he said. A retraction simply says the information 'is unreliable.' 'It doesn't remove it from the world,' he said. However, the transparency of the process varies. Some retraction notices provide no explanation, while others include detailed reasons for the retraction. One of the retracted papers in the list, which question why children are being vaccinated against COVID-19, was withdrawn due to 'unreliable' findings stemming from 'inappropriate bias,' according to the retraction notice. Another paper on COVID-19 vaccination risks was completely withdrawn without any explanation. Oransky told The Fix that full withdrawals are not considered best practice. In other instances, retractions occurred because the author or editor sought further information they wanted to include or because of a technical error that occurred during the study that affected the results. The College Fix reached out to the publisher of the COVID vaccination risk study, Elsevier , seeking an answer as to why the paper was removed without an explanation. The publisher said because the article was published in 2020, it wouldn't be able to determine why it was withdrawn within a reasonable amount of time. Click here to read more Also read: Trump Could Be About To Ban COVID Vaccines; Report
Yahoo
27-01-2025
- Health
- Yahoo
Patient Monitoring Market Size is Projected to Reach USD 112.47 Billion by 2033, Growing at a CAGR of 7.3%: Straits Research
The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% during the forecast period (2025-2033). New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- A set of instruments known as a patient monitoring system enables medical professionals to monitor a patient's health. These gadgets—remote physiologic monitoring—are routinely used for remote patient monitoring. Utilizing digital technology, they gather and track patient health data, transmit it electronically to healthcare specialists, and use it to aid in condition evaluation, diagnosis, and treatment. This technology alters how healthcare is delivered in the US by reducing costs and improving patient outcomes. Patient monitoring systems are easier to define in terms of their uses. One well-known example of a patient monitoring system is electrocardiography (ECG), which records the heart's electrical activity. Hypertensive patients use monitoring tools to keep an eye on their blood pressure. People with diabetes utilize glucose monitoring equipment to assess blood glucose levels and prevent potentially dangerous consequences. Patients with chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions also require monitoring equipment. Download Free Sample Report PDF @ Market Dynamics Growing Adoption of Remote Patient Monitoring Drives the Global Market Recent years have seen a significant increase in the usage of patient monitoring devices for continuous vital sign monitoring and analysis, particularly during the COVID-19 outbreak. Patient monitoring systems enable medical personnel to monitor patients' health remotely or at home. Healthcare can become more digitalized to lower costs and boost revenue for medical practices. Additionally, remote monitoring equipment that provided medical treatment in a comfortable setting and permitted remote monitoring from patients' homes was helpful for non-COVID-19 patients who needed chronic care. This increased the number of beds and other important clinical resources available in hospitals and other healthcare facilities for patients who required immediate on-site care. Due to stringent government regulations and favorable laws for patient monitoring equipment, it is anticipated that many organizations will be motivated to develop novel pharmaceuticals for treating chronic diseases like cardiovascular and respiratory diseases, cancers, diabetes, and chronic respiratory diseases. The widespread use of patient monitoring tools in clinical research trials and the convenience of monitoring is made possible by the market penetration of these tools, which hastens the development of novel medications. The increased prevalence of chronic diseases directly impacts the utilization of ICUs. Due to the benefits offered by patient monitoring devices, such as shorter hospital stays, fewer adverse effects, and speedier recovery times, the market is predicted to grow profitably. Rising Demand in Non-Hospital Creates Tremendous Opportunities The sustainability of the current healthcare system is a serious worry for governments worldwide. Due to escalating healthcare expenditures, particularly in hospital settings, the focus has recently switched to alternative treatment modalities, including home healthcare. In addition, the frequency of hospital readmissions has dramatically decreased since the introduction of remote and home monitoring technology. There is consequently a growing demand for effective home medical devices, such as fetal and neonatal monitors, ECG recorders, temperature monitors, pulse oximeters, and event monitors. Regional Analysis North America is the most significant patient monitoring market shareholder and is estimated to exhibit a CAGR of 8.1% over the forecast period. 42.7% of the market for patient monitoring devices was in North America. This results from several things: its well-established healthcare infrastructure, high healthcare spending, monopolistic market participants, and the rapid adoption of cutting-edge technologies. North America has the most developed medical equipment market worldwide. The market is anticipated to be driven by the quick adoption of patient monitoring and homecare devices for routine, continuous, and long-term patient monitoring and reducing the number of hospital visits during the projected period. Additionally, favorable payment terms are expected to accelerate market expansion. Additional factors anticipated to drive market expansion include the rise in accidents, sports injuries, and health problems associated with lifestyle. Increased emergency care needs and increased usage of mobile surgery centers are expected to drive the market during the forecasted period. Europe is anticipated to exhibit a CAGR of 8.4% over the forecast period. Europe accounted for 25.1% of the global market for patient monitoring devices in 2020. Europe's market includes countries including Germany, France, Italy, Spain, and the United Kingdom. The increasing demand for patient monitoring devices and central data management systems for accurate information and medical services is expected to boost the market. Market expansion is fueled by the prevalence of diseases and the growing older population. In 2020, more than one-fifth of people in Europe were over 65. In Europe, the leading cause of illness and mortality is chronic disease. The requirement for patient monitoring devices has increased due to the number of patients admitted to healthcare facilities. The COVID-19 pandemic has increased the usage of patient monitoring devices and remote monitoring to assess and analyze vital signs in healthcare settings. To obtain more exact and accurate results economically, advanced patient monitoring devices are constantly being developed and presented by various market participants. As a result, the market for patient monitoring devices is anticipated to grow during the period in question. Ask for Customization @ Key Highlights The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% during the forecast period (2025-2033). Based on the product, the global patient monitoring market is bifurcated into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, other. The blood glucose segment dominates the global market and is projected to exhibit a CAGR of 9.1% over the forecast period. Based on end-users, the global patient monitoring market is divided into Hospitals, Ambulatory Surgery Centers, Home Care Settings, and Others. The hospital segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 8.2% over the forecast period. North America is the most significant global patient monitoring market shareholder and is estimated to exhibit a CAGR of 8.1% over the forecast period. Competitive Players Abbott Boston Scientific Medtronic Philips Nihon Kohden Health Anywhere Inc. Koninklijke Philips N.V. G.E. Healthcare MASIMO CORPORATION Smiths Medical Bosch Biotronik Intel Welch Allyn Recent Developments In June 2023, With the introduction of its Generation (Gen) 1 device, medical diagnostic company Know Labs provides the first non-invasive glucose monitor. The Generation (Gen) 1 gadget prototype uses radio waves and machine learning algorithms to measure blood sugar levels through the skin. In May 2023, Royal Philips, a global leader in health technology, and Masimo, a global medical technology company, announced FDA clearance for SedLine® Brain Function Monitoring, Regional Oximetry (O3®), and CO2 measurements in Philips Patient Monitors – IntelliVue MX750 and MX850. The latest extension will let clinicians make quick and informed judgments without additional monitoring equipment. Segmentation By Product Blood Glucose Monitoring Systems Cardiac Monitoring Devices Multiparameter Monitoring Devices Respiratory Monitoring Devices Temperature Monitoring Devices Hemodynamic/Pressure Monitoring Devices Fetal and Neonatal Monitoring Devices Neuromonitoring Devices Weight Monitoring Devices By End-User Hospitals Ambulatory Surgery Centers Home Care Settings By Region North America Europe Asia-Pacific Latin America The Middle East and Africa Get Detailed Market Segmentation @ About Straits Research Pvt. Ltd. Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI. Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client's purchase. We overcome our clients' issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches. Phone: +1 646 905 0080 (U.S.) +44 203 695 0070 (U.K.) Email: sales@ Follow Us: LinkedIn | Facebook | Instagram | Twitter
